Perkirol2 mg
Tablet
Medicine overview
Indications of Perkirol 2 mg
Theropeutic Class
Pharmacology
Perkirol 2 mg binds the dopamine receptors D3 and D2.
Although the precise mechanism of action of Perkirol 2 mg as a treatment for Parkinson's disease is unknown, it is believed to be related to its ability to stimulate these receptors in the striatum.
This conclusion is supported by electrophysiologic studies in animals that have demonstrated that Perkirol 2 mg influences striatal neuronal firing rates via activation of dopamine receptors in the striatum and the substantia nigra, the site of neurons that send projections to the striatum.
Dosage & Administration of Perkirol 2 mg
| Condition | Dosage | Notes |
|---|---|---|
| In all clinical studies, dosage was initiated at a sub therapeutic level and gradually titrated to therapeutic response. The dosage should be increased to achieve a maximum therapeutic effect, balanced against the principal side effects of nausea, dizziness, somnolence and dyskinesia. The recommended starting dose is 0.25 mg three times daily with or without food. Based on individual patient response, dosage should then be titrated with weekly increments as described in the table below. After week 4, if necessary, daily dosage may be increased by 1.5 mg per day on a weekly basis up to a dose of 9 mg per day, and then by up to 3 mg per day weekly to a total dose of 24 mg per day | ||
| Ascending-Dose Schedule of Perkirol 2 mg | First week: 0.25 mg three times daily | |
| Total Daily Dose | 0.75 mg Second week: 0.5 mg three times daily | |
| Total Daily Dose | 1.5 mg Third week: 0.75 mg three times daily | |
| Total Daily Dose | 2.25 mg Fourth week: 1.0 mg three times daily | |
| Total Daily Dose | 3.0 mg Dosage greater than 24 mg/day have not been tested in clinical trials | Perkirol 2 mg should be discontinued gradually over a 7 day period. The frequency of administration should be reduced from three times daily to twice daily for 4 days. For the remaining 3 days, the frequency should be reduced to once daily prior to complete withdrawal of Perkirol 2 mg |
Dosage of Perkirol 2 mg
| Condition | Dosage | Notes |
|---|---|---|
| Dosing for Parkinson's disease | The recommended starting dose for Parkinson's disease is 0.25 mg three times daily | Based on individual patient therapeutic response and tolerability, if necessary, the dose should then be titrated with weekly increments as described below. Maximum recommended total daily dose of 24 mg (8 mg three times daily) |
| Week 1 | 0.25 mg 3 times daily | |
| Total Daily Dose 0.75 mg Week 2 | 0.5 mg 3 times daily | |
| Total Daily Dose 1.50 mg Week 3 | 0.75 mg 3 times daily | |
| Total Daily Dose 2.25 mg Week 4 | 1 mg 3 times daily | Total Daily Dose 3 mg Dosing for Restless Legs Syndrome: The recommended adult starting dose for RLS is 0.25 mg once daily 1 to 3 hours before bedtime. After 2 days, if necessary, the dose can be increased to 0.5 mg once daily, and to 1 mg once daily at the end of the first week of dosing, then as shown below as needed to achieve efficacy. Titration should be based on individual patient therapeutic response and tolerability, up to a maximum recommended dose of 4 mg daily |
| Days 1 and 2 | 0.25 mg, 1 to 3 hours before bedtime, to be taken once daily Days 3-7: 0.5 mg, 1 to 3 hours before bedtime, to be taken once daily Days 2: 1 mg, 1 to 3 hours before bedtime, to be taken once daily Days 3: 1.5 mg, 1 to 3 hours before bedtime, to be taken once daily Days 4: 2 mg, 1 to 3 hours before bedtime, to be taken once daily Days 5: 2.5 mg, 1 to 3 hours before bedtime, to be taken once daily Days 6: 3 mg, 1 to 3 hours before bedtime, to be taken once daily Days 7: 4 mg, 1 to 3 hours before bedtime, to be taken once daily |
Interaction of Perkirol 2 mg
Contraindications
Side Effects of Perkirol 2 mg
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects of Perkirol 2 mg
Storage Conditions
Use In Special Populations
Drug Classes
Mode Of Action
Pregnancy
Frequently Asked Questions
What is Perkirol 2 mg used for?
Ropinirole is indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease. It is also indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
What is the dosage of Perkirol 2 mg?
Dosing for Parkinson's disease: The recommended starting dose for Parkinson's disease is 0.25 mg three times daily. Based on individual patient therapeutic response and tolerability, if necessary, the dose should then be titrated with weekly increments as described below. Maximum recommended total daily dose of 24 mg (8 mg three times daily). Week 1: 0.25 mg 3 times daily. Total Daily Dose 0.75 mg…
What are the side effects of Perkirol 2 mg?
The most common side effects of Ropinirole include fainting, drowsiness, hallucinations, dizziness, nausea or vomiting, uncontrolled sudden movements, leg swelling, fatigue, confusion, headache, upset stomach, abdominal pain or discomfort, increased sweating etc.
Who should not take Perkirol 2 mg?
It is contraindicated in patients known to have a hypersensitivity to Ropinirole.
What precautions should be taken with Perkirol 2 mg?
Patients treated with Ropinirole have reported falling asleep while engaged in activities of daily living. Dopamine agonists in clinical trials and clinical experience appear to impair the systemic regulation of blood pressure, with resulting orthostatic hypotension.
Is Perkirol 2 mg safe during pregnancy and breastfeeding?
Pregnancy: Pregnancy category C. There are no adequate and well-controlled studies using Ropinirole in pregnant women. Ropinirole should be used during pregnancy only if the potential benefit outweighs the potential risk of the fetus.Nursing Mothers: Ropinirole inhibits prolactin secretion in humans and could potentially inhibit lactation. Because of the potential for serious adverse reactions in …
The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.